help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benbassat, C.
Right arrow Articles by Lowe, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benbassat, C.
Right arrow Articles by Lowe, W. L., Jr.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Endocrinology Vol. 140, No. 7 3073-3081
Copyright © 1999 by The Endocrine Society

ARTICLES

Growth Hormone-Mediated Regulation of Insulin-Like Growth Factor I Promoter Activity in C6 Glioma Cells1

Carlos Benbassat, Lungile N. N. Shoba, Marsha Newman, Martin L. Adamo, Stuart J. Frank and William L. Lowe, Jr.

Department of Medicine (C.B., L.N.N.S., M.N., W.L.L.), Veterans’ Affairs Chicago Healthcare System, Lakeside Division, and Northwestern University Medical School, Chicago, Illinois 60611; Department of Biochemistry (M.L.A.), University of Texas Health Science Center, San Antonio, Texas 78284-7760; Department of Medicine (S.J.F.), University of Alabama at Birmingham and Birmingham Veterans’ Affairs Medical Center, Alabama 35294

Address all correspondence and requests for reprints to: William L. Lowe, Jr., M.D., Center for Endocrinology, Metabolism, and Molecular Medicine, Tarry 15–703, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611. E-mail: wlowe{at}nwu.edu

The molecular mechanisms by which GH regulates insulin-like growth factor (IGF-I) gene expression remain obscure. One difficulty has been the lack of established GH-responsive cell lines that express the IGF-I gene. To develop such a cell line, we used rat C6 glioma cells which, as determined by RNase protection assay, express the IGF-I gene but not the GH receptor gene. To confer GH responsiveness, C6 cells were cotransfected with vectors that express the GH receptor (pRc/CMV WTrGHR) and Jak2 (pRc/CMV Jak2). GH responsiveness was demonstrated using luciferase reporter genes containing either the Sis-inducible element from the c-fos gene (pTK81-SIE-Luc) or 6 copies of the GH-responsive GAS-like element (GLE) from the rat spi2.1 gene (pSpi-GLE-Luc). The SIE is activated by binding of STAT1 and 3, whereas the GLE binds STAT5. In cells cotransfected with pRc/CMV WTrGHR, pRc/CMV Jak2, and either pTK81-SIE-Luc or pSpi GLE-Luc, treatment with 500 ng/ml GH for 24 h stimulated a 3.1- and 1.7-fold increase in luciferase activity, respectively. These data suggest that in C6 cells cotransfected with pRc/CMV WTrGHR and pRc/CMV Jak2, GH activates STAT1, 3, and 5. To determine whether GH-responsive IGF-I promoter activity could be demonstrated, C6 cells were cotransfected with pRc/CMV WTrGHR, pRc/CMV Jak2, and an IGF-I-luciferase fusion gene that contained a fragment of the rat IGF-I gene that extended from -412 in the 5'-flanking region of exon 1 to the Met-22 in exon 3. GH stimulated a modest, but reproducible, 1.7-fold increase in luciferase activity in these cells, suggesting that a GH-responsive element is present in this region of the IGF-I gene. To better localize the GH-responsive element, cells were cotransfected with pRc/CMV WTrGHR, pRc/CMV Jak2 plus one of several IGF-I-luciferase fusion genes containing either fragments of one of the two promoters in the IGF-I gene or a fragment of intron 2 that includes a GH-responsive DNase I hypersensitivity site. For all constructs, treatment with GH for 24 h did not stimulate a significant increase in luciferase activity, suggesting that GH-responsive sequences are not located in these specific regions of the IGF-I gene or that GH-directed transcription of the IGF-I gene is mediated via several different regions of the IGF-I gene and the effect of any one of these regions in isolation was not sufficiently robust to be detected in this model system. In summary, transient expression of the GH receptor and Jak2 in C6 cells creates a GH-responsive system that activates STAT1, 3, and 5. Moreover, a fragment of the IGF-I gene that contains exons 1 and 2, a fragment of exon 3, and introns 1 and 2 is GH responsive using this model system.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
S. J. Frank, X. Wang, K. He, N. Yang, P. Fang, R. G. Rosenfeld, V. Hwa, T. R. Chaudhuri, L. Deng, and K. R. Zinn
In Vivo Imaging of Hepatic Growth Hormone Signaling
Mol. Endocrinol., November 1, 2006; 20(11): 2819 - 2830.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Endocr. Rev., December 1, 2005; 26(7): 916 - 943.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank
Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor
Endocrinology, November 1, 2005; 146(11): 4755 - 4765.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
L. Rosengren, H. Simko, L. Aryan, P. Axelsson-Lendin, J. Chmielewska, A. Mode, and V. Parrow
Antisense and Sense RNA Probe Hybridization to Immobilized Crude Cellular Lysates: A Tool to Screen Growth Hormone Antagonists
J Biomol Screen, April 1, 2005; 10(3): 260 - 269.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Wang and H. Jiang
Identification of a Distal STAT5-binding DNA Region That May Mediate Growth Hormone Regulation of Insulin-like Growth Factor-I Gene Expression
J. Biol. Chem., March 25, 2005; 280(12): 10955 - 10963.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank
Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements
Mol. Endocrinol., June 1, 2004; 18(6): 1471 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Yoshizato, M. Tanaka, N. Nakai, N. Nakao, and K. Nakashima
Growth Hormone (GH)-Stimulated Insulin-Like Growth Factor I Gene Expression Is Mediated by a Tyrosine Phosphorylation Pathway Depending on C-Terminal Region of Human GH Receptor in Human GH Receptor-Expressing Ba/F3 Cells
Endocrinology, January 1, 2004; 145(1): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. He, X. Wang, J. Jiang, R. Guan, K. E. Bernstein, P. P. Sayeski, and S. J. Frank
Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling
Mol. Endocrinol., November 1, 2003; 17(11): 2211 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. E. McCall, D. L. Allen, F. Haddad, and K. M. Baldwin
Transcriptional regulation of IGF-I expression in skeletal muscle
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C831 - C839.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Woelfle, J. Billiard, and P. Rotwein
Acute Control of Insulin-like Growth Factor-I Gene Transcription by Growth Hormone through Stat5b
J. Biol. Chem., June 13, 2003; 278(25): 22696 - 22702.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S.-O. Kim, K. Loesch, X. Wang, J. Jiang, L. Mei, J. M. Cunnick, J. Wu, and S. J. Frank
A Role for Grb2-Associated Binder-1 in Growth Hormone Signaling
Endocrinology, December 1, 2002; 143(12): 4856 - 4867.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. L. K. Goh, T. Zhu, W.-Y. Leong, and P. E. Lobie
c-Cbl Is a Negative Regulator of GH-Stimulated STAT5-Mediated Transcription
Endocrinology, September 1, 2002; 143(9): 3590 - 3603.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. B. O'Brien, J. J. O'Shea, and C. Carter-Su
SH2-B Family Members Differentially Regulate JAK Family Tyrosine Kinases
J. Biol. Chem., March 1, 2002; 277(10): 8673 - 8681.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. S. Chacko and M. L. Adamo
Double-Stranded RNA Decreases IGF-I Gene Expression in a Protein Kinase R-Dependent, but Type I Interferon-Independent, Mechanism in C6 Rat Glioma Cells
Endocrinology, February 1, 2002; 143(2): 525 - 534.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. W. Davey, T. Xie, M. J. McLachlan, R. J. Wilkins, D. J. Waxman, and D. R. Grattan
STAT5b Is Required for GH-Induced Liver Igf-I Gene Expression
Endocrinology, September 1, 2001; 142(9): 3836 - 3841.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. L. Sadowski, T. T. Wheeler, L.-H. Wang, and H. B. Sadowski
GH Regulation of IGF-I and Suppressor of Cytokine Signaling Gene Expression in C2C12 Skeletal Muscle Cells
Endocrinology, September 1, 2001; 142(9): 3890 - 3900.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. S. Chacko and M. L. Adamo
Double-Stranded Ribonucleic Acid Decreases C6 Rat Glioma Cell Numbers: Effects on Insulin-Like Growth Factor I Gene Expression and Action
Endocrinology, October 1, 2000; 141(10): 3546 - 3555.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society